Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Arrhythmias

  Free Subscription


Articles published in J Thromb Thrombolysis

Retrieve available abstracts of 28 articles:
HTML format
Text format



Single Articles


    November 2018
  1. MASOTTI L, Grifoni E, Dei A, Vannucchi V, et al
    Direct oral anticoagulants in the early phase of non valvular atrial fibrillation-related acute ischemic stroke: focus on real life studies.
    J Thromb Thrombolysis. 2018 Nov 23. pii: 10.1007/s11239-018-1775.
    PubMed     Text format     Abstract available


  2. HOWE Z, Naville-Cook C, Cole D
    Bleeding rates of Veterans taking apixaban or rivaroxaban for atrial fibrillation or venous thromboembolism.
    J Thromb Thrombolysis. 2018 Nov 17. pii: 10.1007/s11239-018-1770.
    PubMed     Text format     Abstract available


  3. CHOPARD R, Piazza G, Hurwitz S, Fanikos J, et al
    Fatal warfarin-associated intracranial hemorrhage in atrial fibrillation inpatients.
    J Thromb Thrombolysis. 2018 Nov 17. pii: 10.1007/s11239-018-1767.
    PubMed     Text format     Abstract available


    October 2018
  4. BOLEK T, Samos M, Skornova I, Stanciakova L, et al
    Does proton pump inhibition change the on-treatment anti-Xa activity in xabans-treated patients with atrial fibrillation? A pilot study.
    J Thromb Thrombolysis. 2018 Oct 4. pii: 10.1007/s11239-018-1748.
    PubMed     Text format     Abstract available


  5. SOKOL J, Nehaj F, Ivankova J, Mokan M, et al
    First evidence: rivaroxaban and apixaban reduce thrombin-dependent platelet aggregation.
    J Thromb Thrombolysis. 2018;46:393-398.
    PubMed     Text format     Abstract available


  6. CAPPELLARI M, Turcato G, Forlivesi S, Micheletti N, et al
    Introduction of direct oral anticoagulant within 7 days of stroke onset: a nomogram to predict the probability of 3-month modified Rankin Scale score > 2.
    J Thromb Thrombolysis. 2018;46:292-298.
    PubMed     Text format     Abstract available


    September 2018
  7. HIRSH RACCAH B, Rottenstreich A, Zacks N, Muszkat M, et al
    Drug interaction as a predictor of direct oral anticoagulant drug levels in atrial fibrillation patients.
    J Thromb Thrombolysis. 2018 Sep 8. pii: 10.1007/s11239-018-1738.
    PubMed     Text format     Abstract available


    August 2018
  8. MAZUR P, Myc J, Natorska J, Plens K, et al
    Impaired fibrinolysis in degenerative mitral and aortic valve stenosis.
    J Thromb Thrombolysis. 2018;46:193-202.
    PubMed     Text format     Abstract available


  9. POLNAK JF, Delate T, Clark NP
    The influence of fibrate initiation on INR and warfarin dose in patients receiving chronic warfarin therapy.
    J Thromb Thrombolysis. 2018;46:264-270.
    PubMed     Text format     Abstract available


    July 2018
  10. JACKSON LR 2ND, Kim S, Shrader P, Blanco R, et al
    Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
    J Thromb Thrombolysis. 2018 Jul 26. pii: 10.1007/s11239-018-1715.
    PubMed     Text format     Abstract available


  11. AGIRBASLI M
    Quality of direct oral anticoagulant therapy in elderly patients with non-valvular atrial fibrillation.
    J Thromb Thrombolysis. 2018 Jul 25. pii: 10.1007/s11239-018-1717.
    PubMed     Text format    


    June 2018
  12. CHI G, Yee MK, Kalayci A, Kerneis M, et al
    Total bleeding with rivaroxaban versus warfarin in patients with atrial fibrillation receiving antiplatelet therapy after percutaneous coronary intervention.
    J Thromb Thrombolysis. 2018 Jun 26. pii: 10.1007/s11239-018-1703.
    PubMed     Text format     Abstract available


  13. KHEIRI B, Haykal T, Abdalla A, Osman M, et al
    Non-vitamin K antagonist oral anticoagulants in cardioversion of atrial fibrillation: a network meta-analysis.
    J Thromb Thrombolysis. 2018 Jun 15. pii: 10.1007/s11239-018-1694.
    PubMed     Text format    


  14. HUGHEY AB, Gu X, Haymart B, Kline-Rogers E, et al
    Warfarin for prevention of thromboembolism in atrial fibrillation: comparison of patient characteristics and outcomes of the "Real-World" Michigan Anticoagulation Quality Improvement Initiative (MAQI(2)) registry to the RE-LY, ROCKET-AF, and ARISTOTLE
    J Thromb Thrombolysis. 2018 Jun 14. pii: 10.1007/s11239-018-1698.
    PubMed     Text format     Abstract available


  15. MONAGLE SR, Hirsh J, Bhagirath VC, Ginsberg JS, et al
    Impact of cost on use of non-vitamin K antagonists in atrial fibrillation patients in Ontario, Canada.
    J Thromb Thrombolysis. 2018 Jun 5. pii: 10.1007/s11239-018-1692.
    PubMed     Text format     Abstract available


    May 2018
  16. ROSSI AP, Facchinetti R, Ferrari E, Nori N, et al
    Predictors of self-reported adherence to direct oral anticoagulation in a population of elderly men and women with non-valvular atrial fibrillation.
    J Thromb Thrombolysis. 2018 May 14. pii: 10.1007/s11239-018-1679.
    PubMed     Text format     Abstract available


  17. HOYER C, Filipov A, Neumaier-Probst E, Szabo K, et al
    Impact of pre-admission treatment with non-vitamin K oral anticoagulants on stroke severity in patients with acute ischemic stroke.
    J Thromb Thrombolysis. 2018;45:529-535.
    PubMed     Text format     Abstract available


  18. FASULLO S, Davi S, Cosenza G, Di Franco F, et al
    Acute agranulocytosis after oral administration of dabigatran: a rare case report and a short review of literature.
    J Thromb Thrombolysis. 2018;45:588-592.
    PubMed     Text format     Abstract available


    April 2018
  19. GRANT SJ, Kothari S, Gimotty PA, Gooneratne NS, et al
    Quality of direct oral anticoagulant prescribing in elderly patients with non-valvular atrial fibrillation: results from a large urban health system.
    J Thromb Thrombolysis. 2018 Apr 2. pii: 10.1007/s11239-018-1651.
    PubMed     Text format     Abstract available


    February 2018
  20. BRUNETTI ND, Tarantino N, De Gennaro L, Correale M, et al
    Direct oral anti-coagulants compared to vitamin-K antagonists in cardioversion of atrial fibrillation: an updated meta-analysis.
    J Thromb Thrombolysis. 2018 Feb 5. pii: 10.1007/s11239-018-1622.
    PubMed     Text format     Abstract available


    January 2018
  21. XIANG E, Ahuja T, Raco V, Cirrone F, et al
    Anticoagulation prescribing patterns in patients with cancer.
    J Thromb Thrombolysis. 2018;45:89-98.
    PubMed     Text format     Abstract available


    December 2017
  22. RUSSO V, Rago A, Papa AA, D'Onofrio A, et al
    Efficacy and safety of dabigatran in patients with atrial fibrillation scheduled for transoesophageal echocardiogram-guided direct electrical current cardioversion: a prospective propensity score-matched cohort study.
    J Thromb Thrombolysis. 2017 Dec 19. pii: 10.1007/s11239-017-1599.
    PubMed     Text format     Abstract available


  23. SHIN H, Cho MC, Kim RB, Kim CH, et al
    Laboratory measurement of apixaban using anti-factor Xa assays in acute ischemic stroke patients with non-valvular atrial fibrillation.
    J Thromb Thrombolysis. 2017 Dec 2. pii: 10.1007/s11239-017-1590.
    PubMed     Text format     Abstract available


    July 2017
  24. PIPILIS A, Makrygiannis S, Anagnostou G, Kaliampakos S, et al
    Dabigatran plasma levels, aPTT and thromboelastography in patients with AF: implications for allowing early non-elective surgical procedures.
    J Thromb Thrombolysis. 2017;44:9-13.
    PubMed     Text format     Abstract available


    June 2017
  25. HELMERT S, Marten S, Mizera H, Reitter A, et al
    Effectiveness and safety of apixaban therapy in daily-care patients with atrial fibrillation: results from the Dresden NOAC Registry.
    J Thromb Thrombolysis. 2017 Jun 22. doi: 10.1007/s11239-017-1519.
    PubMed     Text format     Abstract available


    March 2017
  26. STEPPICH B, Dobler F, Brendel LC, Hessling G, et al
    Effect of the FXa inhibitors Rivaroxaban and Apixaban on platelet activation in patients with atrial fibrillation.
    J Thromb Thrombolysis. 2017 Mar 18. doi: 10.1007/s11239-017-1495.
    PubMed     Text format     Abstract available


    February 2017
  27. MARSICO F, Cecere M, Parente A, Paolillo S, et al
    Effects of novel oral anticoagulants on left atrial and left atrial appendage thrombi: an appraisal.
    J Thromb Thrombolysis. 2017;43:139-148.
    PubMed     Text format     Abstract available


    August 2016
  28. ROSWELL RO, Greet B, Shah S, Bernard S, et al
    Intravenous heparin dosing strategy in hospitalized patients with atrial dysrhythmias.
    J Thromb Thrombolysis. 2016;42:179-85.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: